Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)
Clinical trial NCT01182350 · TERMINATED
Trial details
- NCT number
- NCT01182350
- Sponsor
- Karen D. Wright MD
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2016-06-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.